Open AccessAbobotulinumtoxinA Treatment of Glabellar Lines Using a New Reconstitution and Injection Volume: Randomized, Placebo-Controlled Data
Author(s) -
Joel Schlessinger,
Daniel P. Friedmann,
Flor Mayoral,
Deanne Mraz Robinson,
DeeAnna Glaser,
Douglas C. Wu,
Keith Marcus,
Michael Somenek,
Xiaoming Lin
Publication year - 2021
Publication title -
journal of drugs in dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.701
H-Index - 62
ISSN - 1545-9616
DOI - 10.36849/jdd.6130
Subject(s) - medicine , placebo , vial , randomized controlled trial , clinical endpoint , adverse effect , patient satisfaction , surgery , chemistry , alternative medicine , pathology
Increasing the reconstitution and injection volumes of abobotulinumtoxinA (aboBoNT-A) could provide more options for aesthetic healthcare professionals.